decisionhealth Newsletters, Coder Pink Sheets - 2016 Issue 4 (April)
2016 Medicare drug screen codes and reimbursement
Subscribe or sign in to view the full article.
Article Overview
This article explains a 2016 Medicare update affecting drug screening billing under the clinical laboratory fee schedule. It is useful for laboratory professionals, coders, and billing staff who need to understand the revised code set, the broad categories of testing covered, and the published reimbursement limits tied to the change.
Why This Topic Matters
Accurate awareness of Medicare drug testing code updates helps avoid billing errors and supports correct charge capture under the 2016 clinical laboratory fee schedule.
Article Sections
-
Medicare drug screen code update
Introduces the 2016 change to Medicare drug testing billing and identifies the prior code groups being replaced. Provides the effective date and the general context for the update.
-
Presumptive tests
Summarizes the presumptive testing category and notes the limitation on reporting within this group. Lists the associated reimbursement information for the codes in this section.
-
Definitive tests
Summarizes the definitive testing category and notes the limitation on reporting within this group. Lists the associated reimbursement information for the codes in this section.
What You Will Learn
- What Medicare drug testing billing changes took effect in 2016
- How the article organizes presumptive and definitive testing categories
- What type of fee schedule guidance is provided alongside the updated code set
- Which public reimbursement topics are associated with the update
Who Should Read This
- Medical coders
- Laboratory billing staff
- Compliance staff
- Revenue cycle professionals
- Pathology and clinical laboratory teams
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com